Clinical Trial Update: Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL [Phase 1]

View source ↗

Summary

Phase 1 study of TAA-specific cytotoxic T lymphocytes (TACTAL) for Hodgkin lymphoma and non-Hodgkin lymphoma; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• TACTAL

Snippet

Sponsor: Baylor College of Medicine | Conditions: Hodgkin Lymphoma, Non-Hodgkin Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING